These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 14756541)

  • 21. Relative Prognostic and Predictive Value of Gene Signature and Histologic Grade in Estrogen Receptor-Positive, HER2-Negative Breast Cancer.
    Iwamoto T; Kelly C; Mizoo T; Nogami T; Motoki T; Shien T; Taira N; Hayashi N; Niikura N; Fujiwara T; Doihara H; Matsuoka J
    Clin Breast Cancer; 2016 Apr; 16(2):95-100.e1. PubMed ID: 26631838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A DEEP LEARNING APPROACH FOR CANCER DETECTION AND RELEVANT GENE IDENTIFICATION.
    Danaee P; Ghaeini R; Hendrix DA
    Pac Symp Biocomput; 2017; 22():219-229. PubMed ID: 27896977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomolecular features of clinical relevance in breast cancer.
    Daidone MG; Paradiso A; Gion M; Harbeck N; Sweep F; Schmitt M
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S3-14. PubMed ID: 15095022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A brief review on long noncoding RNAs: a new paradigm in breast cancer pathogenesis, diagnosis and therapy.
    Malih S; Saidijam M; Malih N
    Tumour Biol; 2016 Feb; 37(2):1479-85. PubMed ID: 26662315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood-based protein biomarkers in breast cancer.
    Núñez C
    Clin Chim Acta; 2019 Mar; 490():113-127. PubMed ID: 30597138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MMP13 is potentially a new tumor marker for breast cancer diagnosis.
    Chang HJ; Yang MJ; Yang YH; Hou MF; Hsueh EJ; Lin SR
    Oncol Rep; 2009 Nov; 22(5):1119-27. PubMed ID: 19787229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrantly methylated DNA as a biomarker in breast cancer.
    Kristiansen S; Jørgensen LM; Guldberg P; Sölétormos G
    Int J Biol Markers; 2013; 28(2):141-50. PubMed ID: 23564623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic Pathology and Biomarkers in Breast Cancer.
    Zhang Z; Tang P
    Crit Rev Oncog; 2017; 22(5-6):411-426. PubMed ID: 29604921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.
    Shukla HD; Mahmood J; Vujaskovic Z
    Cancer Lett; 2015 Dec; 369(1):28-36. PubMed ID: 26276717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic utility of epigenetics in breast cancer - A review.
    Bhat SA; Majid S; Wani HA; Rashid S
    Cancer Treat Res Commun; 2019; 19():100125. PubMed ID: 30802811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hereditary breast cancer: genetic bases and clinical features].
    Brunet J; Alonso MC; Ojeda B
    Med Clin (Barc); 1994 Nov; 103(16):623-7. PubMed ID: 7996921
    [No Abstract]   [Full Text] [Related]  

  • 32. The future of blood-based biomarkers for the early detection of breast cancer.
    Loke SY; Lee ASG
    Eur J Cancer; 2018 Mar; 92():54-68. PubMed ID: 29413690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The emerging role of the molecular diagnostics laboratory in breast cancer personalized medicine.
    De Abreu FB; Wells WA; Tsongalis GJ
    Am J Pathol; 2013 Oct; 183(4):1075-1083. PubMed ID: 23920325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrating text mining, data mining, and network analysis for identifying genetic breast cancer trends.
    Jurca G; Addam O; Aksac A; Gao S; Özyer T; Demetrick D; Alhajj R
    BMC Res Notes; 2016 Apr; 9():236. PubMed ID: 27112211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ANDROMEDA prospective cohort study: predictive value of combined criteria to tailor breast cancer screening and new opportunities from circulating markers: study protocol.
    Giordano L; Gallo F; Petracci E; Chiorino G; Segnan N;
    BMC Cancer; 2017 Nov; 17(1):785. PubMed ID: 29166878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers.
    Hamam R; Hamam D; Alsaleh KA; Kassem M; Zaher W; Alfayez M; Aldahmash A; Alajez NM
    Cell Death Dis; 2017 Sep; 8(9):e3045. PubMed ID: 28880270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Routine molecular applications and recent advances in breast cancer diagnostics.
    Pankotai-Bodó G; Oláh-Németh O; Sükösd F; Pankotai T
    J Biotechnol; 2024 Jan; 380():20-28. PubMed ID: 38122830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes of breast cancer staging when AJCC prognostic staging manual is used: a retrospective analysis of a Chinese cohort.
    Ding J; Wu W; Fang J; Chu Y; Zheng S; Jiang L
    Int J Biol Markers; 2018 May; 33(2):168-173. PubMed ID: 28967067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast cancer biomarkers: proteomic discovery and translation to clinically relevant assays.
    Chung L; Baxter RC
    Expert Rev Proteomics; 2012 Dec; 9(6):599-614. PubMed ID: 23256671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast cancer classification: linking molecular mechanisms to disease prognosis.
    Taherian-Fard A; Srihari S; Ragan MA
    Brief Bioinform; 2015 May; 16(3):461-74. PubMed ID: 24950687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.